Alora

Short answer “Bioidentical” hormones are molecules that have the exact same chemical structure as the hormones produced by the human body (for example 17β‑estradiol, micronized progesterone). “Standard” HRT (hormone replacement therapy) can use either bioidentical hormones or non‑bioidentical (synthetic or animal‑derived) hormones — and includes FDA‑approved products with standardized doses, labeling, and safety data. The main practical differences are how the products are made, regulated and tested — not the idea that “bioidentical” products are automatically safer or more effective. Definitions and examples Bioidentical: chemically identical to human hormones. Examples available as FDA‑approved products include estradiol tablets and patches (Estrace, Vivelle‑Dot, Climara, Alora), estradiol vaginal products (Vagifem, Estring), and micronized progesterone (Prometrium). Non‑bioidentical / standard HRT: includes conjugated equine estrogens (Premarin) and synthetic progestins (medroxyprogesterone acetate — Provera), plus other FDA‑approved estrogen/progestin combinations. Compounded “bioidentical” hormones Many compounding pharmacies make custom mixtures (creams, troches, capsules) and label them “bioidentical.” These are not FDA‑approved products. They are made to individual prescriptions and may include combinations or doses not available commercially. Risks of compounded products: variable potency and purity, inconsistent dosing between batches, fewer safety and efficacy studies, and less regulatory oversight. FDA has warned consumers about unsupported safety claims by some compounding vendors. Safety and effectiveness FDA‑approved HRT products have gone through quality control and clinical testing; their risks and benefits are better documented. There is no high‑quality evidence that compounded bioidentical hormones are safer or more effective than FDA‑approved HRT. Common HRT risks (some depending on type, dose, route, and whether progesterone is used): increased risk of venous thromboembolism (higher with oral estrogens), possible increased breast cancer risk with combined estrogen‑progestin (as seen in WHI for certain formulations), stroke, and cardiovascular effects (risk varies by age and years since menopause). Some differences by formulation: transdermal estradiol (patch) is associated with lower VTE risk than oral estrogen in many studies. Micronized progesterone (Prometrium) may have a different safety profile than synthetic progestins, but data are not definitive. Common misconceptions “Natural” or “bioidentical” does not automatically mean safer. Saliva hormone testing used to “tailor” doses is not a validated method for guiding menopausal HRT dosing. Compounded preparations are not always necessary; many needs can be met with commercial, FDA‑approved products. When a compounded product may be considered If you have a true allergy to an ingredient in all FDA‑approved options, If you need a dose or combination not commercially available and after discussing risks/benefits, Then use a licensed, reputable compounding pharmacy and clear documentation for follow‑up. Practical advice Discuss goals (hot flashes, night sweats, vaginal dryness, bone protection), medical history (personal/family history of breast cancer, clotting disorders, cardiovascular disease), and risk factors with your clinician. Prefer FDA‑approved products when possible for predictable dosing and safety data. Consider route: vaginal products for local dyspareunia/vaginal atrophy; transdermal patches/gels to reduce VTE risk for those at higher clot risk; oral options for convenience in some people. Use the lowest effective dose for the shortest time needed, and have periodic reassessment. If considering compounded BHRT, ask about lot testing, stability, sterility, credentials of the pharmacy, and avoid relying on saliva tests. If you want, I can: Compare specific products that match your symptoms and risk profile (e.g., transdermal estradiol patch brands vs oral tablets), Explain progesterone vs progestin choices for uterine protection, Or summarize risks tailored to your age and medical history.

Mentioned in position 4 of 9

Short answer: for most people who need systemic estrogen, the transdermal route (patch or gel) is generally safer than oral estrogen—especially with regard to blood clots (venous thromboembolism) and some liver/metabolic effects. Why: Oral estrogens go through the liver first (“first‑pass”), which raises clotting factors, increasing VTE risk (and can raise triglycerides and affect CRP). Multiple studies and meta‑analyses show oral menopausal estrogen is associated with a higher VTE risk than transdermal. Transdermal estradiol (patch or gel) delivers hormone directly into the bloodstream, avoids the first‑pass hepatic effect, gives steadier blood levels, and is not associated with the same increase in VTE risk in observational studies. Oral estrogen may also increase gallbladder disease more than transdermal. Both routes carry other risks that depend on dose, whether a progestin is also used (required if you have a uterus), age, time since menopause, and personal risk factors (smoking, obesity, prior clots, thrombophilia, stroke, active cancer). Practical choices (brand examples): Transdermal patches: Climara, Vivelle‑Dot (Evra in some countries), Alora, Minivelle — commonly used for lower VTE risk and steady estradiol levels. Transdermal gels/solutions: EstroGel, Divigel — alternatives if you don’t like patches. Oral tablets: Estrace (micronized estradiol) or Premarin (conjugated equine estrogens) — used widely but have higher hepatic effects than transdermal. Other important points: If you have a history of VTE, known thrombophilia (e.g., factor V Leiden), recent stroke, or active liver disease, systemic estrogen may be contraindicated — and transdermal is usually preferred over oral only after specialist input. If you have a uterus, you’ll usually need a progestogen as well to prevent endometrial hyperplasia. Micronized progesterone (Prometrium) is often used and may have a different side‑effect profile than some synthetic progestins. Use the lowest effective dose for the shortest time needed and review periodically. Avoid unregulated “compounded bioidentical” products unless closely supervised (they’re not FDA‑standardized). Next step: discuss your personal medical history (age, smoking, clot history, cardiovascular risk, family history of thrombosis or breast cancer, whether you still have your uterus) with your clinician to choose route, dose, and whether you need progestogen. I can help you list questions to bring to your provider or summarize risks based on specific personal factors if you want.

Mentioned in position 4 of 10

Short answer: there’s no one “best” BHRT delivery method — pellets, creams, and patches each have pros and cons. The right choice depends on which hormones you need, how steady you want levels to be, tolerance for procedures, safety profile, and how closely you want to be monitored. Below is a concise comparison and a list of commonly used brand/clinic options. 1) Pellets How they work: Small subcutaneous pellets (estradiol and/or testosterone) are implanted under the skin every 3–6 months to give steady hormone release. Pros: Very steady levels; low daily maintenance; good for people who dislike daily dosing. Cons: Minor surgical procedure for insertion/removal; dose adjustment requires re-implantation at the next interval; infection/bleeding risk; dosing is less flexible. Who offers them: BioTE Medical (popular pellet system and provider network), SottoPelle (European-style pellet therapy), many private hormone clinics and anti-aging/functional medicine practices that work with compounding pharmacies. Compounding pharmacies that supply pellets include Wedgewood Pharmacy and some local compounding pharmacies. 2) Topical creams/gels How they work: Compounded or commercial creams/gels applied to skin; transdermal absorption of estradiol, progesterone, or testosterone (absorption varies). Pros: Flexible dosing; noninvasive; easy to stop or change dose. Cons: Absorption is highly variable between people and body sites; risk of transfer to partners/children by skin contact; many creams are compounded (not FDA-reviewed), so potency/consistency can vary. Who offers them: Most compounding pharmacies (Empower Pharmacy, Wedgewood, Belmar and many local compounding pharmacies) produce BHRT creams. Clinics that commonly prescribe topical BHRT include BodyLogicMD, Defy Medical, and many integrative/anti-aging practices. Note: some products (topical testosterone gels like AndroGel, Testim) are FDA-approved for men, but many BHRT creams are compounded. 3) Patches How they work: Adhesive transdermal patches deliver estradiol (and in some cases testosterone) through the skin with relatively steady blood levels. Pros: Predictable, consistent delivery; easier dosing changes than pellets; FDA-approved patches exist for estradiol. Cons: Skin irritation; visible patch; daily/episodic replacement required; fewer progesterone patch options and limited FDA-approved testosterone patches (Androderm for men). Common FDA-approved brands: Vivelle-Dot (estradiol patch), Climara (estradiol patch), Alora (estradiol patch), Estraderm. For testosterone, Androderm is an approved transdermal patch for men (women’s use is off-label). Many clinics also prescribe compounded patches in some cases. Safety/regulation notes “Bioidentical” refers to chemical structure, but many compounded BHRT products are not FDA-approved and may have variable potency. Estradiol patches and some oral progesterone products (Prometrium, which is micronized progesterone) are FDA-approved. All forms of estrogen and testosterone carry potential risks (blood clots, stroke, breast cancer risk context-dependent, cardiovascular effects, etc.). Progesterone and dosing also affect risk. Safety depends on your age, medical history, and which hormones are used. Creams can transfer to partners/children. Pellets are a small surgical procedure. Patches can irritate skin. How to choose See a clinician experienced in hormone therapy (gynecologist, endocrinologist, or a reputable hormone clinic). They’ll base choice on symptoms, lab results, risk factors, lifestyle, and willingness for procedures. Prefer methods with good evidence for your situation; if you’re choosing compounded products, use a reputable compounding pharmacy and get follow-up labs. If you want the most predictable, adjustable FDA-regulated dosing: patches or FDA-approved topical formulations are a safer-first choice. Pellets are attractive for convenience and steady levels but are less adjustable and require a procedure. Who to contact / where to get them Pellet-focused: BioTE Medical providers, SottoPelle-trained clinicians (search each organization’s provider locator). Multi-method hormone clinics/telemedicine: BodyLogicMD, Defy Medical, Evernow (telehealth hormone care), and many local integrative medicine practices will prescribe patches, creams, or pellets depending on assessment. Compounding pharmacies (for creams/pellets when a compounded product is chosen): Wedgewood Pharmacy, Empower Pharmacy, Belmar Pharmacy and numerous accredited local compounding pharmacies (verify accreditation and reviews). For FDA-approved patch/gel products: see your regular prescriber (PCP, OB/GYN) who can prescribe brands like Vivelle-Dot, Climara, Androderm, AndroGel, Testim, or Prometrium where appropriate. If you want, I can: Help you compare two specific options (e.g., BioTE pellets vs Climara patch) for a specific hormone profile or condition. Find local clinicians or telemedicine providers that offer a given method in your area (tell me your city/zip).

Mentioned in position 12 of 16

Short answer BHRT (bioidentical hormone replacement therapy) is hormone therapy that uses hormones chemically identical to the ones your body makes (examples: estradiol, progesterone, testosterone). It’s most commonly used to treat symptoms of menopause, perimenopause, surgical menopause, and some forms of hormone deficiency in men. You “need” it only if your symptoms or medical condition and an individualized risk/benefit discussion with a clinician point to hormone therapy as the best option. What BHRT means “Bioidentical” refers to the chemical structure of the hormone being the same as human hormones. Some bioidentical hormones are available as FDA‑approved pharmaceuticals (estradiol, micronized progesterone, testosterone products); others are custom-compounded by pharmacies (cream, troche, pellets) and are less well regulated. Important distinction: FDA‑approved products come with standardized dosing, manufacturing oversight, and safety data. Compounded BHRT is tailored but has more variability and limited safety data. Who might benefit Women with moderate–severe menopausal symptoms: hot flashes, night sweats, sleep disruption, severe vaginal dryness/pain with sex, or mood problems linked to hormonal changes. Women with premature ovarian insufficiency or surgical menopause (younger than typical menopause) often benefit from hormones for symptom control and bone protection. Men with clinically confirmed low testosterone and consistent symptoms (low libido, fatigue, muscle loss) may be evaluated for testosterone therapy. People with documented hormone deficiencies identified and managed by an experienced clinician. How to tell if you need BHRT — steps to take Document your symptoms (type, severity, effect on daily life). See an appropriate clinician: gynecologist with menopause expertise, reproductive endocrinologist, endocrinologist, urologist (men), or a primary care clinician experienced in hormone care. Medical evaluation: medical history, physical exam, review of risks (personal/family history of breast cancer, blood clots, stroke, cardiovascular disease, liver disease). Targeted testing: Women: FSH or estradiol can help in some cases (but levels fluctuate — clinical symptoms are often more important). Consider bone density (DEXA) if indicated. Men: morning total testosterone on two separate occasions plus other labs (LH, prolactin) as indicated. Beware of saliva/urine hormone tests routinely used by some compounding clinics — these are generally not recommended for dosing because results don’t reliably predict clinical outcomes. Shared decision: if benefits (symptom relief, bone protection) outweigh risks, start the lowest effective dose and monitor. Treatment options and examples (brands and why) Transdermal estradiol patches — Vivelle‑Dot, Climara, Alora: widely used, avoid first‑pass liver metabolism (lower clot risk than some oral estrogens). Oral estradiol — Estrace: standardized dosing and safety data. Vaginal products for local symptoms — Vagifem (vaginal tablet), Estring (vaginal ring), low‑dose vaginal estradiol creams: effective for vaginal dryness and urinary symptoms with low systemic exposure. Progesterone (to protect the uterus if you have one) — Prometrium (micronized progesterone): bioidentical progesterone in FDA‑approved form; has different side‑effect profile than synthetic progestins like medroxyprogesterone (Provera). Testosterone (men) — AndroGel, Testim: approved preparations for men with documented low testosterone. Testosterone for women is used off‑label in some cases but no widely approved female formulation in the U.S.; use cautiously and under specialist care. Pellet therapies and compounded BHRT — brands such as BioTE or SottoPelle offer pellet implants and compounding pharmacies make custom creams/gels. These are popular with some patients but carry concerns: variable dosing, infection risk, limited safety data, and less regulatory oversight. Risks and monitoring Hormone therapy has risks: venous thromboembolism (blood clots), stroke, possible increase in some breast cancer risks (especially with combined estrogen + certain progestins), and others that depend on age, timing of initiation, formulation, dose, and personal medical history. Standard practice: use the lowest effective dose for the shortest time needed, regular follow‑up visits, and periodic re-evaluation of risks/benefits. Screening (mammography, blood pressure, lipids, DEXA when indicated) continues as appropriate. Alternatives Non-hormonal treatments for hot flashes: SSRIs/SNRIs (venlafaxine, paroxetine), gabapentin, clonidine; CBT for insomnia/mood; vaginal moisturizers or lubricants for local symptoms. Lifestyle measures: smoking cessation, weight management, regular exercise, cooling strategies. Next steps I recommend If you have bothersome symptoms: make an appointment with a clinician experienced in menopause/hormone care (a gynecologist with menopause training, an endocrinologist, or a board‑certified menopause practitioner). The North American Menopause Society (NAMS.org) has clinician directories and patient resources. Bring a list of symptoms, medical history, and be prepared to discuss family history of breast cancer, blood clots, and heart disease. Ask about evidence, alternatives, monitoring plan, and whether your clinician prefers FDA‑approved bioidentical products or compounded formulations and why. If you want, tell me your sex, age, main symptoms, and any relevant medical history (blood clots, breast cancer, heart disease, smoking) and I can give more tailored guidance on whether BHRT might be reasonable and what questions to ask a clinician.

Mentioned in position 3 of 12

Short answer: “Bioidentical” hormone therapy can be safe and effective for many patients when it’s prescribed and monitored by a knowledgeable clinician, but safety depends on which products are used, the patient’s health risks, dose, route, and duration. Major medical groups do not endorse unregulated compounding pharmacies’ marketing claims that compounded BHRT is safer or more natural than standard, FDA‑approved hormone therapy. Key points doctors and medical societies say Two categories matter: FDA‑approved “bioidentical” hormones (molecules identical to human estradiol or progesterone) — e.g., oral estradiol (Estrace), transdermal estradiol patches (Vivelle‑Dot, Climara, Alora), vaginal estradiol (Vagifem, Estring), and micronized progesterone (Prometrium). These have standardized dosing, manufacturing controls, and safety data. Compounded BHRT from compounding pharmacies (creams, troches, custom mixes). These are not FDA‑approved as finished products, have variable quality and dose consistency, and lack large controlled trials proving superior safety or effectiveness. Professional societies (North American Menopause Society, Endocrine Society, ACOG) advise: use FDA‑approved hormone therapies when possible; avoid claims that compounded BHRT is inherently safer; get individualized risk assessment (cardiovascular disease, blood clot history, breast cancer risk, stroke). Risks: hormone therapy can raise risk of blood clots and stroke (especially certain formulations and in older women), and combined estrogen+progestin was linked to an increased breast cancer risk in the Women’s Health Initiative. Timing, type (estradiol vs conjugated equine estrogen), route (transdermal vs oral), and whether you use micronized progesterone vs synthetic progestins affect risk profiles. Testing: many doctors warn against using salivary hormone tests or broad hormone panels to tailor doses — they’re unreliable. Dosing should be guided by symptoms, blood tests when appropriate, and follow‑up. Practical, evidence‑based recommendations (what doctors typically advise) If possible, choose FDA‑approved products first (examples: Estrace, Vivelle‑Dot, Climara, Vagifem, Prometrium) because manufacturing and dosing are standardized. Use the lowest effective dose for the shortest time needed, reassess symptoms and risks periodically. If you’re considering compounded BHRT, use a reputable, PCAB‑accredited compounding pharmacy and discuss why an FDA‑approved product isn’t suitable for you. Avoid providers who rely heavily on saliva testing or claim BHRT is risk‑free or prevents aging; seek a menopause specialist, gynecologist, or endocrinologist. If you have a history of breast cancer, active cardiovascular disease, prior venous thromboembolism, or high stroke risk, discuss nonhormonal options and specialist input. Specific brands/services (examples and why) Estrace (oral estradiol) — FDA‑approved, well‑studied estradiol formulation. Vivelle‑Dot, Climara, Alora (transdermal estradiol patches) — patches often have lower clot risk than similar oral doses and are useful for systemic menopausal symptom control. Vagifem, Estring (local vaginal estradiol) — effective for local genitourinary symptoms with low systemic exposure. Prometrium (micronized progesterone) — a bioidentical progesterone available as an FDA‑regulated product; sometimes preferred over synthetic progestins for endometrial protection. PCAB‑accredited compounding pharmacies (e.g., Wedgewood, Belmar — examples) — if you must use compounded BHRT, choose an accredited pharmacy for better quality control. Trusted clinical resources: North American Menopause Society (NAMS), American College of Obstetricians and Gynecologists (ACOG), Endocrine Society — use their guidelines and patient fact sheets to discuss risks and benefits with your clinician. For specialty care: major centers (Mayo Clinic Menopause Clinic, Cleveland Clinic Women’s Health, Johns Hopkins Menopause Clinic) — if you want an expert consult about complex risks or compounded therapy. Next steps for you Talk with your primary care doctor, OB/GYN, or an endocrinologist/menopause specialist about your symptoms and medical history. Ask whether an FDA‑approved formulation is appropriate and why/why not a compounded product is needed. Review personal risks (heart disease, clotting, breast cancer) and plan monitoring (symptom review, periodic exams, and tests as indicated). If prescribed compounded BHRT, ask that it come from a PCAB‑accredited pharmacy and request batch testing/quality documentation. If you tell me your age, current symptoms, medical history (cardiovascular disease, prior clots, breast cancer, smoking), and whether you prefer oral, patch, or local therapy, I can give more tailored options and which brands are most commonly used.

Mentioned in position 4 of 9

Short answer There’s no single “best” delivery method — pellets, creams/gels and patches each have tradeoffs. The right choice depends on which hormones you need, how stable you want blood levels, how adjustable you want dosing, your medical risks (clotting, breast cancer, liver disease), and your tolerance for minor procedures. For steady, infrequent dosing choose pellets; for an FDA‑standard, predictable transdermal option choose patches; for flexible dosing or topical/local effects choose creams/gels — but be aware creams have the most absorption variability and transfer risk. Talk with a menopause specialist or your clinician and get appropriate baseline labs and follow‑up. What each type does, plus pros/cons Pellets (subcutaneous implants) What: Solid pellets (usually estradiol and/or testosterone) are placed under the skin every ~3–6 months and release hormone continuously. Pros: Very steady hormone levels, no daily dosing, good for people who dislike daily meds. Cons: Minor surgical procedure to insert/remove, risk of infection or pellet extrusion, dose is not easily changed once inserted, many pellets are compounded (variable quality). Not ideal if you expect to need rapid dose changes. Who offers it: BioTE (large network/training company), SottoPelle (clinician network specializing in pellet therapy), and many anti‑aging/menopause clinics and some telemedicine clinics (e.g., certain specialty providers such as Defy Medical offer pellet services). Patches (transdermal patches) What: Adhesive patches that deliver estradiol (and commercially in men, testosterone) through the skin. Pros: Predictable, FDA‑approved options for estradiol (good systemic control), lower risk of first‑pass liver effects than oral hormones, dose adjustments are straightforward, no insertion procedure. Cons: Skin irritation, patches can fall off, visible, need regular application/change. Common FDA‑approved brands (mostly for estradiol): Vivelle‑Dot, Climara, Alora, Minivelle, Menostar. For testosterone in men: Androderm/AndroGel (testosterone gels/patches are typically for men; women’s testosterone is often compounded). Creams/gels (topical/transdermal) What: Hormone gels or creams rubbed on the skin or used vaginally (vaginal creams deliver local effects with lower systemic exposure). Pros: Easy to start/stop and change dose, can be compounded to individualized doses, good for local vaginal symptoms (vaginal estradiol creams like Estrace are FDA‑approved for local use). Cons: Highly variable absorption between people and sites of application, higher risk of transferring hormone to others by skin contact, many preparations are compounded (variable quality), systemic levels can be unpredictable requiring careful monitoring. Brands/services: Estrace cream (vaginal estradiol, FDA‑approved). For systemic “bioidentical” creams many providers use compounding pharmacies (see below). Safety/regulatory notes “Bioidentical” simply means chemically identical to human hormones (estradiol, progesterone, testosterone). Some FDA‑approved products use bioidentical hormones (e.g., estradiol patches/gels, oral micronized progesterone [Prometrium], vaginal estradiol creams). However, many BHRT creams and pellets are compounded — compounding is not FDA‑standardized and product potency/sterility can vary. Because pellets are often compounded and implantation is a minor surgical procedure, you should choose an experienced provider and discuss infection/other risks. Hormone therapy decisions must consider personal history (breast cancer, clotting disorders, cardiovascular disease, liver disease). Always review risks/benefits with a clinician. Who to see / where to get them For patches/approved topical products: see your primary care, OB/GYN, or menopause clinic — they can prescribe FDA‑approved patches (Vivelle‑Dot, Climara), estradiol gels, or oral progesterone (Prometrium). For pellets: look for clinicians affiliated with pellet networks (BioTE, SottoPelle) or experienced menopause/anti‑aging clinics. Ask about training, complication rates, and follow‑up protocols. For compounded creams/gels: use a reputable compounding pharmacy (look for accreditation such as PCAB accreditation or USP compliance). Examples of widely known compounding pharmacies include Wedgewood Pharmacy and Empower Pharmacy (ask your clinician for local recommendations). Telemedicine clinics that specialize in hormone therapy can arrange testing and prescriptions but verify they use accredited labs and safe compounding/implantation practices. Practical guidance to choose Decide goals: systemic symptom control (hot flashes, mood, libido) vs local vaginal symptoms vs testosterone replacement. Consider convenience: pellets = low maintenance; patches = weekly/daily routine; creams = daily and more user‑dependent. Consider adjustability: patches/creams easier to titrate than pellets. Consider safety/history: if you have clot risk or breast cancer history, discuss alternatives and risks with a specialist. If using compounded products, insist on an accredited pharmacy and documented lab testing and follow‑up. If you’d like, tell me: Which hormones you’re considering (estradiol, progesterone, testosterone)? Any medical history (blood clots, breast cancer, liver disease, migraines)? Whether you prefer fewer clinic visits or maximal dose control? I can then suggest the most appropriate route and name specific clinics or products in your area or online.

Mentioned in position 6 of 14